2015
Association between radiation dose and outcomes with postoperative radiotherapy for N0-N1 non-small-cell-lung cancer.
Wang E, Corso C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Association between radiation dose and outcomes with postoperative radiotherapy for N0-N1 non-small-cell-lung cancer. Journal Of Clinical Oncology 2015, 33: 7538-7538. DOI: 10.1200/jco.2015.33.15_suppl.7538.Peer-Reviewed Original Research
2011
Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study
Decker R, Gettinger S, Glazer P, Wilson L. Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s574-s575. DOI: 10.1016/j.ijrobp.2011.06.1074.Peer-Reviewed Original Research
2005
The Impact of Radiotherapy for Post-operative Patients with Stage II or Stage III Non-Small Cell Lung Cancer Utilizing the Surveillance, Epidemiology, and End Results Database
Lally B, Wilson L. The Impact of Radiotherapy for Post-operative Patients with Stage II or Stage III Non-Small Cell Lung Cancer Utilizing the Surveillance, Epidemiology, and End Results Database. International Journal Of Radiation Oncology • Biology • Physics 2005, 63: s102-s103. DOI: 10.1016/j.ijrobp.2005.07.176.Peer-Reviewed Original Research